DE:EAJF Stock Latest News
Company AnnouncementsValiRx sees value boost from Ambrose’s AM-Pharma acquisition1w ago
Company AnnouncementsValiRx tightens operations and bolsters cash as it refocuses pipeline and portfolio1M ago
Company AnnouncementsValiRx bolsters Cytolytix cancer IP with new European patent and delivery platform filing2M ago
Company AnnouncementsValiRx AGM Backs Strategy as Board Changes and Large Warrant Issue Follow3M ago
Company AnnouncementsValiRx tightens focus and cuts costs as auditors flag going-concern risk4M ago
Company AnnouncementsValiRx Ends Dundee Evaluation After Cancer Asset Fails Licensing Criteria4M agoCompany AnnouncementsValiRx fast-tracks RNA helicase deal with McGill and plans Canadian spin-out5M ago
Company AnnouncementsValiRx Bolsters Cytolytix IP with New European Patent and Oncolytic Platform Filings5M ago
Company AnnouncementsValiRx Raises £1.16m in Oversubscribed Retail and Placing Fundraise5M ago
Company AnnouncementsValiRx Extends £1.15m Fundraise with UK Retail Share Offer and Attached Warrants5M ago
Company AnnouncementsValiRx launches discounted £1.155m raise to fund IP expansion and animal health push5M ago
Company AnnouncementsValiRx updates registered office as it advances oncology and women’s health focus7M agoCompany AnnouncementsValiRx trims costs and expands oncology pipeline with new human and veterinary initiatives7M ago
Company AnnouncementsValiRx gains oncology spotlight with digital twin data and expanding scientific footprint7M ago
Company AnnouncementsValiRx CEO Increases Stake with 1 Million-Share Purchase8M ago
Company AnnouncementsValiRx launches veterinary oncology arm to tap fast-growing animal cancer market8M ago
Company AnnouncementsValiRx Issues 80,000 New Shares Following Warrant Exercise9M ago
Company AnnouncementsValiRx Strikes RNA Helicase Deal with McGill and IRICoR Under Asset-Focused Funding Model9M ago
Company AnnouncementsValiRx Strikes RNA Helicase Inhibitor Deal with McGill and IRICoR to Drive Asset-Level Growth9M agoCompany AnnouncementsValiRx Advances with New Equity and Warrant Issuance Post-General Meeting11M ago
Company AnnouncementsValiRx PLC Announces Fundraising to Boost Cancer and Women’s Health Research12M ago


